Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

14,435 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
An Integrated Approach Including CRISPR/Cas9-Mediated Nanopore Sequencing, Mate Pair Sequencing, and Cytogenomic Methods to Characterize Complex Structural Rearrangements in Acute Myeloid Leukemia.
Phan M, Gomes MA, Stinnett V, Morsberger L, Hoppman NL, Pearce KE, Smith K, Phan B, Jiang L, Zou YS. Phan M, et al. Among authors: smith k. Biomedicines. 2024 Mar 7;12(3):598. doi: 10.3390/biomedicines12030598. Biomedicines. 2024. PMID: 38540211 Free PMC article.
Clinical Utility of Targeted Next-Generation Sequencing Assay to Detect Copy Number Variants Associated with Myelodysplastic Syndrome in Myeloid Malignancies.
Jiang L, Pallavajjala A, Huang J, Haley L, Morsberger L, Stinnett V, Hardy M, Park R, Ament C, Finch A, Shane A, Parish R, Nozari A, Long P, Adams E, Smith K, Parimi V, Dougaparsad S, Long L, Gocke CD, Zou YS. Jiang L, et al. Among authors: smith k. J Mol Diagn. 2021 Apr;23(4):467-483. doi: 10.1016/j.jmoldx.2021.01.011. Epub 2021 Feb 10. J Mol Diagn. 2021. PMID: 33577993 Free article.
Immunogenicity and safety of a monovalent omicron XBB.1.5 SARS-CoV-2 recombinant spike protein vaccine as a heterologous booster dose in US adults: interim analysis of a single-arm phase 2/3 study.
Alves K, Kotloff K, McClelland RS, Kouassi A, Plested JS, Kalkeri R, Zhu M, Cloney-Clark S, Cai Z, Smith K, Kaba M, Nelson J, Hammershaimb EA, Mallory RM, Noriega F; 2019nCoV-313 Study Investigators. Alves K, et al. Among authors: smith k. Lancet Infect Dis. 2025 Jan 14:S1473-3099(24)00670-4. doi: 10.1016/S1473-3099(24)00670-4. Online ahead of print. Lancet Infect Dis. 2025. PMID: 39824198
14,435 results
You have reached the last available page of results. Please see the User Guide for more information.